Ö. ATEŞ Et Al. , "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer," JOURNAL OF BUON , vol.21, no.2, pp.375-381, 2016
ATEŞ, Ö. Et Al. 2016. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. JOURNAL OF BUON , vol.21, no.2 , 375-381.
ATEŞ, Ö., BABACAN, T., KERTMEN, N., Sarici, F., Cenoli, A., AKIN, S., ... Karakas, Y.(2016). Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. JOURNAL OF BUON , vol.21, no.2, 375-381.
ATEŞ, ÖZTÜRK Et Al. "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer," JOURNAL OF BUON , vol.21, no.2, 375-381, 2016
ATEŞ, ÖZTÜRK Et Al. "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer." JOURNAL OF BUON , vol.21, no.2, pp.375-381, 2016
ATEŞ, Ö. Et Al. (2016) . "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer." JOURNAL OF BUON , vol.21, no.2, pp.375-381.
@article{article, author={ÖZTÜRK ATEŞ Et Al. }, title={Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer}, journal={JOURNAL OF BUON}, year=2016, pages={375-381} }